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Revised Maine HIV Testing 
Laws Go Into Effect 
An "Act to Implement the Recommendations of the Maine HIV 
Advisory Committee Concerning HIV Testing" was heard before the Maine 
State Legislature this spring. After several changes and revisions, the bill, LD 
321 , was passed by the House & Senate and signed into law by Governor 
Angus King on July 3, 1 995. 
The new law amends and clarifies several major areas around which 
confusion had existed in the past, particularly regarding the definition of an 
HIV test, the meaning and handling of occupational exposure for both the 
exposed and the source, the handling of medical records and informed 
consent, the handling and content of pre and post-test counseling, and 
restrictions on requiring HIV tests or revealing HIV test results. 
Key areas of the law are summarized below. 
HIV Test Definition: 
The new law makes clear that an "HIV Test" means not only a test of 
the presence of antibodies to HIV, but also any test that looks for the 
presence of an HIV antigen or any other diagnostic determinants specific for 
HIV infection. This would include P-24 antigens, as well as newer tests such 
as PCR for B-DNA or HIV RNA Written informed consent must be obtained 
prior to doing any test included within this definition. Informed consent is not 
required for repeated HIV testing by health care providers to monitor the 
course of established infection. Anonymous test sites continue to be exempt 
from the requirement that the informed consent be in writing. 
HIV Pre & Post Test Counseling: (see Insert) 
Medical Records 
This section of the law underwent only minor amendments. 
Key parts continue to be as follows: 
• When any medical record entry is made concerning 
information of a person's HIV infection status, including the 
results of an HIV test, the person who is the subject of the 
HIV test must elect in writing whether to authorize the release 
of that portion of the medical record containing the HIV 
status information when that person's medical record has 
been requested. A new written election must be made 
when a change in the person's HIV infection status occurs or 
whenever the person chooses to make a new election. The 
written election should be obvious and clearly notable in the 
record. 
FDA Considers Home 
Testing Kits for HIV 
Several kits for home use 
for HIV testing now await approval 
by the FDA 
Current tests rely on home 
collection with samples then sent 
to a lab for testing and 
interpretation. Examples include 
blood testing methods and a 
saliva sampling test (ie. Orasure) . 
Critics of these home tests 
are concerned that sample 
collection may not be correctly 
performed at home, leading to 
inaccurate results. Additionally, 
there are questions regarding the 
effectiveness of telephone post 
test counseling as opposed to a 
face to face encounter. However, 
surveys suggest that the availability 
of these tests could result in 
earlier detection of HIV for a 
substantial number of persons 
who currently do not seek testing 
at other sites. Initial studies of 
some of these test systems 
demonstrate high sensitivity and 
specificity, provided that the test is 
used correctly. A decision by the 







The release form must clearly state 'Nhether or not the 
person has authorized the release of that information, and the 
person must be advised of the potential implications of authorizing 
the release of that information. 
v\"hen release has been authorized in writing, the custodian 
of the medical record may release, upon request, the person's 
medical record, including any HIV infection status information. v\"hen 
release has not been authorized, only that portion of the medical 
record that does not contain HIV infection status information may be 
released upon request. By law, HIV infection status information may 
be released only if the person has specifically authorized a separate 
release of that information. A general release form is insufficient. 
. These cor,fjdentiality laws do not mean that medical records 
cannot be reviewed for utilization review, research, audits, peer 
review, or other such professional reasons. However, such reviews 
may not identify, directly or indirectly, any individual person, tested 
positive or negative, for HIV. 
It is important. however, to be aware that Maine's HIV law 
does mandate that health care providers and others with access to 
medical records containing HIV infection status information must have 
a written policy providing for confidentiality of all patient information, 
and that the policy must require action consistent with disciplinary 
procedures for violations of the confidentiality policy. 
Restrictions on Requiring Tests or Disclosure of Test Results: 
Maine HIV law states that an employee or applicant for 
employment may not be required to submit to an HIV test or to 
reveal 'Nhether they have obtained an HIV test or its results, except 
'Nhen based on a bona fide occupational qualification. Likewise, the 
employment status of an employee may not be affected or changed 
because of the result of any HIV test. ( The Maine Human Rights 
Commission is mandated to enforce this regulation.) 
Bona Fide Occupational Exposure: 
The new Maine HIV law was specifically amended to define 
this term. It means " .. . skin, eye, mucus membrane or parenteral 
contact of a person with the potentially infected blood or other body 
fluids of another person that results from the performance of duties 
by the exposed person in the course of employment." Consent 
need not be obtained 'Nhen the bona fide occupational exposure 
createsa significant risk of infection, provided that a court order has 
been obtained according to the procedure outlined in the law. A 
pertinent amendment in this section specifically states that the fact 
that an HIV test was given as a result of an occupational exposure, 
and the results of that test, may not appear in any records of the 
source person. Pretest and post-test counseling must be offered, 
and the subject of the test may choose not to be informed about 
the result of the test. The specific procedures for obtaining a court 
order are outlined in the law and will not be covered here. 
For more information on how to obtain a copy of the new 
Maine law regarding HIV Testing please call: 
The State of Maine Revisions Office at (207)287-1650. 
CDC Guidelines for HIV 
Counseling and 
Voluntary Testing for 
Pregnant Women 
The Centers for Disease 
Control and Prevention have 
released guidelines that call upon 
medical professionals to provide 
HIV counseling and voluntary 
testing for all pregnant women. 
In 1993 (the most recent 
year for 'Nhich complete data are 
available). an estimated 7,0CJJ HIV-
infected women gave birth in the 
United States. The prevalence of 
HIV infection in women giving birth 
was about 1 .6 per 1 ,OCJJ, or about 
1 in every 625. Assuming an HIV 
transmission rate from mother to 
infant is about 1 5-30%, about 
1 ,OCJJ-2,0CJJ HIV-infected infants 
were born in the U.S. in 1 993. 
The prevalence of HIV 
infection in women giving birth in 
Maine in 1 993 was 0.1 per 1 ,OCJJ 
births of HIV-infected infants in 
Maine per year. 
The finding of a 6 7.5% 
reduction in HIV transmission in 
the NIH Clinical Trial 076 for 
pregnant women taking AZT has 
been a major motivation of the 
current CDC Guidelines. However, 
in low prevalence areas of the 
U.S., the benefit of routine testing 
of pregnant women is still 
controversial. Also. specific issues 
around treatment and strategies 
for insuring drug availability and 
compliance have not been 
resolved. 
Printed copies of the 
guidelines and recommendation of 
the U.S. Public Health Service Task 
Force on the Use of Zidovudine to 
Reduce Perinatal Transmission of 
Human Immunodeficiency Virus 
(MMWR 1994:43 [RR-11]) 'Nhich 
has more information about AZT 
treatment during pregnancy are 
available from the CDC National 
AIDS Clearinghouse Hotline at 
1-800-3452-AJDS. 
/ 
· Summary of Requirements for 
HIV Pre & Post Test Counseling in Maine 
The new law continues the fonner regulation that persons who are the subjects of HIV tests must be offered 
pretest and post-test counseling. However, the new law additionally clarifies that persons offered counseling under this 
section may decline the offer by signing a waiver stating that counseling has been offered and is being declined. 
Pre-Test Counseling must include the following: 
1 . Personal ''face to face" counseling that includes, at a minimum, a discussion of: 
• the nature and reliability of the test being proposed 
• the person to whom the results of the test may be disclosed 
• the purpose for which the test results may be used 
• any reasonably foreseeable risks and benefits resulting from the test 
• infonnation on good HIV prevention practices and HIV risk reduction plans 
2. A written memorandum summarizing the contents of the discussion that includes a written infonned 
consent fonn which may be used to satisfy the requirement for a written memorandum if it contains 
all the required infonnation. 
A 'Nfitten consent form does not satisfy the requirement for personal counseling. 
The provider of an HIV test mav offer group pretest counseling. but individual counseling must be 
provided if the subiect of the test requests it 
Post-Test Counseling must include the following: 
1 . Personal counseling that includes, at a minimum, a discussion of: 
• the test results and the reliability and significance of the test results 
• infonnation on good preventive practices and risk reduction plans 
• referrals for medical care and referrals for support services, including social. emotional support, 
and legal services as needed 
2. A written memorandum summarizing the contents of the discussion given to the person being 
counseled 
3 The offer of face-to-face counseling. If the subject of the test declines, the provider of the test may 
provide an alternative means of providing the infonnation required above. This is an important addition 
to the old law, because it allows telephone or 'Nfitten (in a letter) follow-up if the subject of the test 
refuses or does not show up for post test counseling. 
Sharing or disclosing of HIV test results was also clarified. The subject of an HIV test must designate 
in writing the authorized disclosure of HIV test results to a person or organization providing health care. The 
health care provider may make these results available only to other health care providers working directly with 
the patient, and only for the purpose of providing direct medical or dental care. Any health care provider who 
discloses HIV test results in good faith pursuant to this subjection is immune from any criminal or civil liability 
for the act of disclosing HIV test results to other health care providers. 
Diagnostic Tests for HIV 
Test Sensitivity/Specificity Indications Cost 
Antibody Test: 99% Routine HIV test $20.00 (approx) 
Elisa and Western Blot 
P24 Antigen Low sensitivity Neonatal HIV, Primary HIV $95.00 
syndrome 
PCR or bDNA for HIV 99% sensitivity Neonatal HIV, Primary HIV $200.00 
RNA 1 00% specificity syndrome & confirmation 
of diagnosis in unusual 
case 
Viral Culture high sensitivity Confirmation of diagnosis $200.00 - $500.00 
1 00% specificity in an unusual case 
ANONYMOUS HIV ANTIBODY TESTING LOCATIONS (MAINE) 
Augusta 
Augusta Family Planning 
1 22 State Street 
(207)626-3426 
Appointments booked on 
Monday early AM for 
various days. $20.00 
cash - flat rate 
Ellsworth 
Downeast Family Planning 
PO Box 1087 
(207)66 7 -5304 
(800)492-5550 
Hours: Thursday 8:00 am 
- 4:30 pm. Fee $20.00 -
Rat ($15.00 retest) 
Portland 
The AIDS Proied 
142 High Street, 6th Floor 
(207)775-1267 
(800)851 -2437 
Hours: Monday and 
Wednesday 5:30 - 7: 15 
pm. (Appointments can 
be scheduled Mon-Fri 
9:00-5:00) 
Portland STD Clinic 
389 Congress St, 3rd Fir 
(City Hall) 
(207)87 4-8300ext. 8784 
Hours: Mon-Fri 8:00-5:00 
by appointment and 
based on an emergency 
basis as well. 
Bangor 
Bangor STD Clinic 
103 Texas Avenue 
(207)947-0700 
Hours: Monday - Friday 
B·OOam - 4:30 pm, Wed-
nesday evenings until 
6:30 pm. $15.00 - flat 
rate 
Farmington 
TriCounty Health Services 
1 5 Front Street 
(207) 778-4553 
Hours: Thursday BDOam 
-4:30 pm 
Presque Isle 
ACAP Family Planning 
1 84C Academy Street 
PO Box 1116 
(207)768-3062 
Hours: Monday- Friday 
B·OOam - 5:00pm. $20.00 
cash, flat rate. 
Biddeford 
York County STD Clinic 
Univ. of New England 
11 Hills Beach Road 
(207)282-1516 
Hours: Tuesday 5:30 -
7:00 pm. $20.00 sliding 
scale. 
Lewiston 
The STD Clinic 
PO Box 70 
1 Auburn Center 
(207)795-4019 
Hours: Monday, 
Tuesday, and Thursday 
9:00am - 3:00pm. Fee 
$20. 00 sliding scale 
Rockland 
Mid Coast Family Planning 
22 Vv'hite Street 
(207)594-2551 
Hours: 9:00am - 4:00pm 
$20. 00 flat rate 
It is important to note the difference between "anonymous· and 
•confidential• testi(lg. 
•Anonymous 
There is no name or social security number connected to 
the test, and there is no medical record. The person to be 
tested is assigned a number and this number is the only 
information that links the result to the person being tested. 
If the counselor knows the person to be tested, someone 
else does the counseling to further protect the anonymity 
of that person. 
• Confidential 
A name is connected to the test and there is a medical 
record, but there is a confidentiality agreement that allows 
the person being tested to decide who has access to the 
results. 
The Patient's Perspective 
This issue's ·Patient's Perspective" is written by 
Myles Rightmyre, ""110 is not infected by H/v, but is 
affected by HIV on a da1ty basis. Myles'Job is to provide the pre and post 
test counseling at the City of Portland STD Clinic, and he offers these 
suggestions for providing pre & post test counseling. 
The effectiveness of the post test positive counseling is largely 
determined by the work that has been done in the pretest session. A 
thorough risk evaluation with the patient helps prepare the patient and the 
provide for the result. A sexual/drug use history helps the patient confront 
risk factors that may have long been denied. The combination of 
distinguishing HIV infection and AIDS and explaining the implications of a 
possible positive result allows for teaching at a time when a patient is more 
likely to be able to grasp the information. 
Leaming how a patient thinks he/she might respond to a positive 
result can prepare the provider for the work ahead. Accessing the patients 
support system and evaluating for suicidality together create an opening for 
planning appropriate intervention should a result be positive. Knowing that 
the provider has a plan for the patient's health care should the result be 
positive will increase his/her sense of safety while awaiting a result. 
A positive result should be given face to face in a private meeting 
with the provider. It is important to allow the patient ample time to process 
and ask questions. Most people report that beyond hearing that the result 
was positive, they have no recollection of what may have been discussed in 
the session. Having pamphlets and printed materials on hand (there is 
excellent material currently available) can provide the client with information 
that he/she can grasp when ready to take it in. Referrals to case 
management and support groups are very important as they will allow the 
client to begin to establish a support system or expand an existing one. 
Another concern that both the provider and the patient face centers 
around those sex or needle sharing partners who may have been exposed 
to HIV. The Maine Bureau of Health offers assistance with partner 
notification, if desired. In these cases, counselors visit those named as 
partners in a face to face, quiet, and nonintrusive manner and explain the_ risk 
of exposure without disclosing any information about the source patient, 
including gender, age, race, or times of exposure. Partners who receive 
these visits are offered the chance to test at the time of the visit or they are 
offered referrals to local anonymous test sites if they so prefer. In any case 
pretest counseling is offered, which includes the nature of the test and its 
reliability, confidentiality, and reporting concerns. information on transmission 
and the importance of risk reduction, and referrals to local community based 
support organizations. 
Providers ""110 have not had an HIV positive patient or would !Ike assistance 
or guidance in prepanng for a post-test positive session can ~eceive 
information and support through the Maine Bureaus of Health by cal/mg the 
HIV Prevention Program in Augusta at (207)287-2899 or by calling local 
Bureau of Health reps in Portland at 874-8446, tn Lewiston at 795-4019, and 
tn Bangor at (207)947-07CXJ. 
Update on Diagnostic 
Confirmation of HIV 
The combination of a 
positive ELISA screening test for 
antibodies to HIV coupled with a 
positive Western Blot remains the 
cornerstone of HIV testing. Over 
the years, most of these tests 
have been modified to detect 
both HIV-1 and HIV-2, and provide 
high sensitivity and specificity (98-
1 00%) for HIV infection. Antibody 
tests are not sensitive during the 
first 1 -2 months after exposure, 
but are nearly always positive by 
the third month. 
On occasion, an individual 
will have an indeterminate anti-
body test for HIV characterized by 
a positive ELISA and an 
indeterminate Western Blot. In 
situations of high likelihood for 
infection, this pattern represents 
an early antibody response that 
will become truly positive on 
repeat testing in 1 -2 months. In 
low likelihood situation, indeter-
minate tests usually result from a 
false positive ELISA test. 
Sequential antibody testing with 
ELISA and Western Blot has been 
shown to have a false positive rate 
of less than 1 per 1 OCX). 
In special circumstances, 
tests for the P-24 antigen of HIV 
may be useful. For example, P-24 
antigen testing may be useful in 
confirmation of neonatal infection, 
or during the primary HIV 
syndrome before antibody has 
developed. 
Polymerase chain reaction 
(PCR) testing for HIV RNA is highly 
sensitive and specific, and can be 
useful when antibody tests are not 
interpretable. Roche labs now 
offer HIV PCR testing commercially 
at a cost of approximately 
$200.00. 
Finally, viral culture 
techniques are highly sensitive, but 
often require 2-3 weeks for 
incubation. and are very 
expensive. 
Upcoming HIV/AJDS Education 
World Al OS Cases 
US AIDS Cases 
US Al OS Deaths 
Maine AIDS Cases 
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October 04, 1 995 AJDS Update - Emergency PA Conference, Ramada Inn, Portland ME 
Robert P Smith, MD. 
New Fall Semester Course at U.S.M. 
AJDS: Scientific, Social, & Political Foundations 
Course Summary 
This course will approach HIV/AIDS from a multidisciplinary perspective. It is intended to provide a solid 
introduction to HIV/AIDS for persons who are likely to be confronting AIDS issues in their professional work. 
Scientific topics to be considered include HIV virology, immunology, transmission, and community epidemiology. 
Guest lecturers will also address psychosocial and social aspects of the epidemic, as well as issues in law, 
ethics, and HIV prevention strategies. The course is open to advanced undergraduate and graduate students. 
Faculty 
Geoff Beckett, PA-C, MPH (Principle Instructor), is Assistant State Epidemiologist for Maine, and has worked 
with HIV and related infectious disease issues for more than seven years. 
Steve Fleming (Associate Instructor), has been an HIV Public Health Educator in Maine since 1989 and 
has specialized in community-level HIV prevention efforts. 
Stephen D. Sears, MD, MPH (Associate Instructor) is an infectious disease specialist and HIV/AIDS 
clinicians. 
For further information contact Geoff Beckett at (207)287-5551. 
Maine Medical Center 
AIDS Consultation Service 
22 Bramhall Street 
Portland Maine 04103 
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